Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
Lin Jiang(Fudan University Shanghai Cancer Center), Guan-Hua Su(Shanghai Medical College of Fudan University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), Yajia Gu(Fudan University Shanghai Cancer Center), He Wang(Anhui Medical University), Rencheng Zheng(Shanghai Center for Brain Science and Brain-Inspired Technology), Chao You(Fudan University Shanghai Cancer Center), Bingqing Xia(Shanghai Institute of Materia Medica), Yi Xiao(Shanghai Medical College of Fudan University), Dandan Zhang(Shanghai Jiao Tong University)
Cited by 92
Related Papers
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143